An Integrated Approach for Early In Vitro Sedation Prediction Utilizing hiPSC Neurons and Human Ion Channel Assays

Central nervous system (CNS) liabilities remain a significant cause of failure in drug development. Two complementary in vitro safety assays were previously developed, combining automated patch-clamp electrophysiology and multielectrode array techniques, to detect and avoid seizurogenic compounds. Further to seizure risk, sedation and fatigue are commonly encountered CNS side effects during drug safety testing. Here, the aim was to extend the capability of the in vitro safety assay to enable earlier detection of sedative potential. Fourteen compounds with reported sedative activity and five non-sedative controls were screened in human-induced pluripotent stem cell-derived neurons using multielectrode array. These compounds were further screened with automated patch-clamp electrophysiology using cells expressing CNS ion channels implicated in sedation: K V 1.1, K V 2.1, K V 3.1, K V 7.2/7.3, Na V 1.2, K 2P 2.1, or the α 1 β 2 γ 2 GABA A , and α 4 β 2 nicotinic receptors. Known sedative compounds reduced neural firing and network burst activity in human-induced pluripotent stem cell-neurons, indicating sedative effects, whilst negative control compounds did not significantly change multielectrode array parameters. Of the 19 compounds screened, 94% were accurately classified. Automated patch-clamp electrophysiology confirmed that several sedative compounds interacted with CNS ion channels within a 30-fold margin to their total therapeutic blood plasma concentration. These results support the use of the combined in vitro safety models for detecting sedative as well as seizurogenic effects, offering valuable human-based tools for early hazard identification and prioritization of drug candidates. These platforms are also useful for interpretation of CNS-related findings in vivo supporting the principles of 3Rs to minimize and replace the use of animals in scientific testing.

Authors

Institutions

Publication Details

Journal
International Journal of Toxicology
Published
2026-11-17
DOI
https://doi.org/10.1177/10915818261494181
Primary Topic
Animal testing and alternatives
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

An Integrated Approach for Early In Vitro Sedation Prediction Utilizing hiPSC Neurons and Human Ion Channel Assays

Katie Newman, Louisa Zolkiewski, Magali-Anne Maizières, Michael J. Morton et al.
4 links
International Journal of Toxicology
Animal testing and alternatives
article

An Integrated Approach for Early In Vitro Sedation Prediction Utilizing hiPSC Neurons and Human Ion Channel Assays

Katie Newman, Louisa Zolkiewski, Magali-Anne Maizières, Michael J. Morton, Kimberly L. Rockley, Ruth Angela Roberts, Bethan Kelly, Hannah G. Jennings, Karen Jones
article en

Abstract

Central nervous system (CNS) liabilities remain a significant cause of failure in drug development. Two complementary in vitro safety assays were previously developed, combining automated patch-clamp electrophysiology and multielectrode array techniques, to detect and avoid seizurogenic compounds. Further to seizure risk, sedation and fatigue are commonly encountered CNS side effects during drug safety testing. Here, the aim was to extend the capability of the in vitro safety assay to enable earlier detection of sedative potential. Fourteen compounds with reported sedative activity and five non-sedative controls were screened in human-induced pluripotent stem cell-derived neurons using multielectrode array. These compounds were further screened with automated patch-clamp electrophysiology using cells expressing CNS ion channels implicated in sedation: K V 1.1, K V 2.1, K V 3.1, K V 7.2/7.3, Na V 1.2, K 2P 2.1, or the α 1 β 2 γ 2 GABA A , and α 4 β 2 nicotinic receptors. Known sedative compounds reduced neural firing and network burst activity in human-induced pluripotent stem cell-neurons, indicating sedative effects, whilst negative control compounds did not significantly change multielectrode array parameters. Of the 19 compounds screened, 94% were accurately classified. Automated patch-clamp electrophysiology confirmed that several sedative compounds interacted with CNS ion channels within a 30-fold margin to their total therapeutic blood plasma concentration. These results support the use of the combined in vitro safety models for detecting sedative as well as seizurogenic effects, offering valuable human-based tools for early hazard identification and prioritization of drug candidates. These platforms are also useful for interpretation of CNS-related findings in vivo supporting the principles of 3Rs to minimize and replace the use of animals in scientific testing.

International Journal of Toxicology
University of Birmingham (GB)
Good health and well-being
Animal testing and alternatives
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon